Selected research
Industry Research
Exoskeleton Enhancement Device Industry Research Report 2026
Market perspective
The global Exoskeleton Enhancement Device market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Exoskeleton Enhancement Device is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Exoskeleton Enhancement Device is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Exoskeleton Enhancement Device is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Exoskeleton Enhancement Device include Parker Hannifin, US Bionics, ReWalk Robotics, Panasonic, Myomo, LockHeed Martin, Interactive Motion Technologies, Hocoma and Ekso Bionics, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Exoskeleton Enhancement Device market in terms of revenue (US$ million) and, where applicable, sales volume (Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Exoskeleton Enhancement Device Market by Company
Parker Hannifin
US Bionics
ReWalk Robotics
Panasonic
Myomo
LockHeed Martin
Interactive Motion Technologies
Hocoma
Ekso Bionics
Cyberdyne
B-TEMIA Inc.
Alter G
Exoskeleton Enhancement Device Segment by Type
Lower
Upper
Full Body
Exoskeleton Enhancement Device Segment by Application
Healthcare
Defense
Others
Exoskeleton Enhancement Device Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Exoskeleton Enhancement Device market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Exoskeleton Enhancement Device and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Exoskeleton Enhancement Device.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Exoskeleton Enhancement Device manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Exoskeleton Enhancement Device by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Exoskeleton Enhancement Device in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Lower
- Upper
- Full Body
Applications
- Healthcare
- Defense
- Others
Companies covered
- Parker Hannifin
- US Bionics
- ReWalk Robotics
- Panasonic
- Myomo
- LockHeed Martin
- Interactive Motion Technologies
- Hocoma
- Ekso Bionics
- Cyberdyne
- B-TEMIA Inc.
- Alter G
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Exoskeleton Enhancement Device Market Size (2021-2032)
- 2.2.2 Global Exoskeleton Enhancement Device Sales (2021-2032)
- 2.2.3 Global Exoskeleton Enhancement Device Market Average Price (2021-2032)
- 2.3 Exoskeleton Enhancement Device by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Lower
- 2.3.3 Upper
- 2.3.4 Full Body
- 2.4 Exoskeleton Enhancement Device by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Healthcare
- 2.4.3 Defense
- 2.4.4 Others
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Exoskeleton Enhancement Device Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Exoskeleton Enhancement Device Sales (Units) of Manufacturers (2021-2026)
- 3.3 Global Exoskeleton Enhancement Device Revenue of Manufacturers (2021-2026)
- 3.4 Global Exoskeleton Enhancement Device Average Price by Manufacturers (2021-2026)
- 3.5 Global Exoskeleton Enhancement Device Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Exoskeleton Enhancement Device, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Exoskeleton Enhancement Device, Product Type & Application
- 3.8 Global Manufacturers of Exoskeleton Enhancement Device, Established Date
- 3.9 Global Exoskeleton Enhancement Device Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Parker Hannifin
- 4.1.1 Parker Hannifin Company Information
- 4.1.2 Parker Hannifin Business Overview
- 4.1.3 Parker Hannifin Exoskeleton Enhancement Device Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Parker Hannifin Exoskeleton Enhancement Device Product Portfolio
- 4.1.5 Parker Hannifin Recent Developments
- 4.2 US Bionics
- 4.2.1 US Bionics Company Information
- 4.2.2 US Bionics Business Overview
- 4.2.3 US Bionics Exoskeleton Enhancement Device Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 US Bionics Exoskeleton Enhancement Device Product Portfolio
- 4.2.5 US Bionics Recent Developments
- 4.3 ReWalk Robotics
- 4.3.1 ReWalk Robotics Company Information
- 4.3.2 ReWalk Robotics Business Overview
- 4.3.3 ReWalk Robotics Exoskeleton Enhancement Device Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 ReWalk Robotics Exoskeleton Enhancement Device Product Portfolio
- 4.3.5 ReWalk Robotics Recent Developments
- 4.4 Panasonic
- 4.4.1 Panasonic Company Information
- 4.4.2 Panasonic Business Overview
- 4.4.3 Panasonic Exoskeleton Enhancement Device Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Panasonic Exoskeleton Enhancement Device Product Portfolio
- 4.4.5 Panasonic Recent Developments
- 4.5 Myomo
- 4.5.1 Myomo Company Information
- 4.5.2 Myomo Business Overview
- 4.5.3 Myomo Exoskeleton Enhancement Device Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Myomo Exoskeleton Enhancement Device Product Portfolio
- 4.5.5 Myomo Recent Developments
- 4.6 LockHeed Martin
- 4.6.1 LockHeed Martin Company Information
- 4.6.2 LockHeed Martin Business Overview
- 4.6.3 LockHeed Martin Exoskeleton Enhancement Device Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 LockHeed Martin Exoskeleton Enhancement Device Product Portfolio
- 4.6.5 LockHeed Martin Recent Developments
- 4.7 Interactive Motion Technologies
- 4.7.1 Interactive Motion Technologies Company Information
- 4.7.2 Interactive Motion Technologies Business Overview
- 4.7.3 Interactive Motion Technologies Exoskeleton Enhancement Device Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Interactive Motion Technologies Exoskeleton Enhancement Device Product Portfolio
- 4.7.5 Interactive Motion Technologies Recent Developments
- 4.8 Hocoma
- 4.8.1 Hocoma Company Information
- 4.8.2 Hocoma Business Overview
- 4.8.3 Hocoma Exoskeleton Enhancement Device Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Hocoma Exoskeleton Enhancement Device Product Portfolio
- 4.8.5 Hocoma Recent Developments
- 4.9 Ekso Bionics
- 4.9.1 Ekso Bionics Company Information
- 4.9.2 Ekso Bionics Business Overview
- 4.9.3 Ekso Bionics Exoskeleton Enhancement Device Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Ekso Bionics Exoskeleton Enhancement Device Product Portfolio
- 4.9.5 Ekso Bionics Recent Developments
- 4.10 Cyberdyne
- 4.10.1 Cyberdyne Company Information
- 4.10.2 Cyberdyne Business Overview
- 4.10.3 Cyberdyne Exoskeleton Enhancement Device Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Cyberdyne Exoskeleton Enhancement Device Product Portfolio
- 4.10.5 Cyberdyne Recent Developments
- 4.11 B-TEMIA Inc.
- 4.11.1 B-TEMIA Inc. Company Information
- 4.11.2 B-TEMIA Inc. Business Overview
- 4.11.3 B-TEMIA Inc. Exoskeleton Enhancement Device Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 B-TEMIA Inc. Exoskeleton Enhancement Device Product Portfolio
- 4.11.5 B-TEMIA Inc. Recent Developments
- 4.12 Alter G
- 4.12.1 Alter G Company Information
- 4.12.2 Alter G Business Overview
- 4.12.3 Alter G Exoskeleton Enhancement Device Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 Alter G Exoskeleton Enhancement Device Product Portfolio
- 4.12.5 Alter G Recent Developments
5 Global Exoskeleton Enhancement Device Market Scenario by Region
- 5.1 Global Exoskeleton Enhancement Device Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Exoskeleton Enhancement Device Sales by Region: 2021-2032
- 5.2.1 Global Exoskeleton Enhancement Device Sales by Region: 2021-2026
- 5.2.2 Global Exoskeleton Enhancement Device Sales by Region: 2027-2032
- 5.3 Global Exoskeleton Enhancement Device Revenue by Region: 2021-2032
- 5.3.1 Global Exoskeleton Enhancement Device Revenue by Region: 2021-2026
- 5.3.2 Global Exoskeleton Enhancement Device Revenue by Region: 2027-2032
- 5.4 North America Exoskeleton Enhancement Device Market Facts & Figures by Country
- 5.4.1 North America Exoskeleton Enhancement Device Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Exoskeleton Enhancement Device Sales by Country (2021-2032)
- 5.4.3 North America Exoskeleton Enhancement Device Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Exoskeleton Enhancement Device Market Facts & Figures by Country
- 5.5.1 Europe Exoskeleton Enhancement Device Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Exoskeleton Enhancement Device Sales by Country (2021-2032)
- 5.5.3 Europe Exoskeleton Enhancement Device Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Exoskeleton Enhancement Device Market Facts & Figures by Country
- 5.6.1 Asia Pacific Exoskeleton Enhancement Device Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Exoskeleton Enhancement Device Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Exoskeleton Enhancement Device Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Exoskeleton Enhancement Device Market Facts & Figures by Country
- 5.7.1 South America Exoskeleton Enhancement Device Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Exoskeleton Enhancement Device Sales by Country (2021-2032)
- 5.7.3 South America Exoskeleton Enhancement Device Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Exoskeleton Enhancement Device Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Exoskeleton Enhancement Device Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Exoskeleton Enhancement Device Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Exoskeleton Enhancement Device Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Exoskeleton Enhancement Device Sales by Type (2021-2032)
- 6.1.1 Global Exoskeleton Enhancement Device Sales by Type (2021-2032) & (Units)
- 6.1.2 Global Exoskeleton Enhancement Device Sales Market Share by Type (2021-2032)
- 6.2 Global Exoskeleton Enhancement Device Revenue by Type (2021-2032)
- 6.2.1 Global Exoskeleton Enhancement Device Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Exoskeleton Enhancement Device Revenue Market Share by Type (2021-2032)
- 6.3 Global Exoskeleton Enhancement Device Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Exoskeleton Enhancement Device Sales by Application (2021-2032)
- 7.1.1 Global Exoskeleton Enhancement Device Sales by Application (2021-2032) & (Units)
- 7.1.2 Global Exoskeleton Enhancement Device Sales Market Share by Application (2021-2032)
- 7.2 Global Exoskeleton Enhancement Device Revenue by Application (2021-2032)
- 7.2.1 Global Exoskeleton Enhancement Device Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Exoskeleton Enhancement Device Revenue Market Share by Application (2021-2032)
- 7.3 Global Exoskeleton Enhancement Device Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Exoskeleton Enhancement Device Value Chain Analysis
- 8.1.1 Exoskeleton Enhancement Device Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Exoskeleton Enhancement Device Production Mode & Process
- 8.2 Exoskeleton Enhancement Device Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Exoskeleton Enhancement Device Distributors
- 8.2.3 Exoskeleton Enhancement Device Customers
9 Global Exoskeleton Enhancement Device Analyzing Market Dynamics
- 9.1 Exoskeleton Enhancement Device Industry Trends
- 9.2 Exoskeleton Enhancement Device Industry Drivers
- 9.3 Exoskeleton Enhancement Device Industry Opportunities and Challenges
- 9.4 Exoskeleton Enhancement Device Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst